-
公开(公告)号:TR199800301A2
公开(公告)日:1998-09-21
申请号:TR9800301
申请日:1998-02-24
Applicant: HOECHST AG
Inventor: BRENDEL JOACHIM , LANG HANS JOCHEN , GERLACH UWE
IPC: C07D239/24 , A61K31/18 , A61K31/335 , A61K31/38 , A61K31/39 , A61K31/495 , A61P1/00 , A61P9/00 , C07C311/07 , C07D239/70 , C07D313/08 , C07D321/02 , C07D321/06 , C07D
Abstract: Benzoxepine and benzocycloheptane derivatives of formula (I), their stereoisomers and salts are new. X1 = O, S, SO, SO2, CR1R2, NR6, CO or CR1R7; R1, R2 = H, CF3, C2F5, C3F7, 1-6C alkyl or phenyl (optionally substituted by 1 or 2 of halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me; or R1+R2 = 2-10C alkylene; R6 = H or CnH2nR8 (with one CH2 group optionally replaced by O, CH=CH, C IDENTICAL C, CO, COO, OCO, S, SO, SO2, NR9 or CONR9; R9 = H or 1-4C alkyl; n = 0-8; R8 = H, CF3, C2F5, C3F7, 3-8C cycloalkyl, NMe2, NEt2, piperidino, pyrrolidino, morpholino, 4-methyl-1-piperazinyl or pyridyl, thienyl, imidazolyl or phenyl (all optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); X2 = CR1R2 or CR2R10; or X2 = O, S, SO, SO2 or NR6 if X3 and X1 are CR1R2; R10+R7 = bond; X3 = CR1R2; or X3 = O, S, SO, SO2 or NR6 if X2 and X4 are CR1R2; X4 = CR1R2, NR6, NR11, CH(OR30) or CR2R11; R30 = H, 1-3C alkyl or 1-4C acyl; R11+R5 = bond; Y1-Y4 = CR12 or N with no more than two being N; R12 = H, halo, 1-5C alkyl, 3-8C cycloalkyl, CN, CF3, C2F5, C3F7, N3, NO2, ZCmH2mR13 or phenyl (optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); Z = O, CO, COO, OCO, S, SO, SO2, SO2NR14, NR14 or CONR14; R14 = H or 1-3C alkyl; m = 0-6; R13 = H, CF3, C2F5, C3F7, 3-8C cycloalkyl, NR15R16, CONR15R16, OR30a or phenyl, thienyl or 1-9C N-containing heterocyclyl (all optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); R15, R16 = H or 1-3C alkyl; or R15+R16 = 4-5C methylene (with one carbon optionally replaced by O, S, NH, NMe or N(benzyl)); R30a = H, 1-3C alkyl or 1-4C acyl; or Y1+Y2 = S and Y3, Y4 = CR12; R3 = NR18CxH2xR17 or CxH2xR17 (with one CH2 group optionally replaced by O, CO, S, SO, SO2 or NR19); R19 = H, Me or Et; R17 = H, Me, 3-8C cycloalkyl, CF3, C2F5 or C3F7; x = 0-10; R18 = H or 1-8C alkyl; or R18+R17 = bond if x = 3-10; or R3 = phenyl (optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); or R3+R4 = 3-8C alkylene (with one CH2 optionally replaced by O, CO, S, SO or SO2); R4 = CrH2rR20 (with one CH2 group optionally replaced by O, CH=CH, C IDENTICAL C, CO, COO, OCO, S, SO, SO2, NR21 or CONR21); R21 = H or 1-3C alkyl; r = 0-20; R20 = H, CF3, C2F5, C3F7, 3-8C cycloalkyl, NR22R23 or phenyl, thienyl or 1-9C N-containing heterocyclyl (all optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); R22, R23 = H or 1-3C alkyl; or R22+R23 = 4-5C methylene (with one carbon optionally replaced by O, S, NH, NMe or N(benzyl)); and R5 = H; or R5+R11 = bond.
-
公开(公告)号:AU5633398A
公开(公告)日:1998-09-03
申请号:AU5633398
申请日:1998-02-25
Applicant: HOECHST AG
Inventor: BRENDEL JOACHIM , LANG HANS JOCHEN , GERLACH UWE
IPC: C07D239/24 , A61K31/18 , A61K31/335 , A61K31/38 , A61K31/39 , A61K31/495 , A61P1/00 , A61P9/00 , C07C311/07 , C07D239/70 , C07D313/08 , C07D321/02 , C07D321/06
Abstract: Benzoxepine and benzocycloheptane derivatives of formula (I), their stereoisomers and salts are new. X1 = O, S, SO, SO2, CR1R2, NR6, CO or CR1R7; R1, R2 = H, CF3, C2F5, C3F7, 1-6C alkyl or phenyl (optionally substituted by 1 or 2 of halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me; or R1+R2 = 2-10C alkylene; R6 = H or CnH2nR8 (with one CH2 group optionally replaced by O, CH=CH, C IDENTICAL C, CO, COO, OCO, S, SO, SO2, NR9 or CONR9; R9 = H or 1-4C alkyl; n = 0-8; R8 = H, CF3, C2F5, C3F7, 3-8C cycloalkyl, NMe2, NEt2, piperidino, pyrrolidino, morpholino, 4-methyl-1-piperazinyl or pyridyl, thienyl, imidazolyl or phenyl (all optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); X2 = CR1R2 or CR2R10; or X2 = O, S, SO, SO2 or NR6 if X3 and X1 are CR1R2; R10+R7 = bond; X3 = CR1R2; or X3 = O, S, SO, SO2 or NR6 if X2 and X4 are CR1R2; X4 = CR1R2, NR6, NR11, CH(OR30) or CR2R11; R30 = H, 1-3C alkyl or 1-4C acyl; R11+R5 = bond; Y1-Y4 = CR12 or N with no more than two being N; R12 = H, halo, 1-5C alkyl, 3-8C cycloalkyl, CN, CF3, C2F5, C3F7, N3, NO2, ZCmH2mR13 or phenyl (optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); Z = O, CO, COO, OCO, S, SO, SO2, SO2NR14, NR14 or CONR14; R14 = H or 1-3C alkyl; m = 0-6; R13 = H, CF3, C2F5, C3F7, 3-8C cycloalkyl, NR15R16, CONR15R16, OR30a or phenyl, thienyl or 1-9C N-containing heterocyclyl (all optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); R15, R16 = H or 1-3C alkyl; or R15+R16 = 4-5C methylene (with one carbon optionally replaced by O, S, NH, NMe or N(benzyl)); R30a = H, 1-3C alkyl or 1-4C acyl; or Y1+Y2 = S and Y3, Y4 = CR12; R3 = NR18CxH2xR17 or CxH2xR17 (with one CH2 group optionally replaced by O, CO, S, SO, SO2 or NR19); R19 = H, Me or Et; R17 = H, Me, 3-8C cycloalkyl, CF3, C2F5 or C3F7; x = 0-10; R18 = H or 1-8C alkyl; or R18+R17 = bond if x = 3-10; or R3 = phenyl (optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); or R3+R4 = 3-8C alkylene (with one CH2 optionally replaced by O, CO, S, SO or SO2); R4 = CrH2rR20 (with one CH2 group optionally replaced by O, CH=CH, C IDENTICAL C, CO, COO, OCO, S, SO, SO2, NR21 or CONR21); R21 = H or 1-3C alkyl; r = 0-20; R20 = H, CF3, C2F5, C3F7, 3-8C cycloalkyl, NR22R23 or phenyl, thienyl or 1-9C N-containing heterocyclyl (all optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); R22, R23 = H or 1-3C alkyl; or R22+R23 = 4-5C methylene (with one carbon optionally replaced by O, S, NH, NMe or N(benzyl)); and R5 = H; or R5+R11 = bond.
-
公开(公告)号:HU9700437A2
公开(公告)日:1998-08-28
申请号:HU9700437
申请日:1997-02-13
Applicant: HOECHST AG
Inventor: ALBUS UDO , BRENDEL JOACHIM , KLEEMANN HEINZ-WERNER , LANG HANS JOCHEN , SCHOLZ WOLFGANG , SCHWARK JAN-ROBERT , WEICHERT ANDREAS
IPC: C07D333/24 , A61K31/38 , A61K31/381 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P35/00 , A61P43/00 , C07C279/22 , C07D333/02 , C07D333/34
Abstract: Thiophenylalkenylcarboxylic acid guanidide derivatives of formula (I) and their salts are new. at least one of R1-R3 = Op(CH2)sCqF2q+1, R40CO or R31SOk; and the others = H, F, Cl, Br, I, CN, OnaCmaH2ma+1 or OgaCraH2raR10; p = 0 or 1; s = 0-4; q = 1-8; k = 0-2; R40, R31 = 1-8C alkyl, 1-8C perfluoroalkyl, 3-8C cycloalkyl or Ph (optionally substituted by 1-3 F, Cl, CF3, Me or OMe) or NR41R42; R41,R42 = H, 1-4C alkyl or 1-4C perfluoroalkyl; or R41+R42 = (CH2)x in which a CH2 group may be replaced by O, S, NH, NMe or N-benzyl; x = 4 or 5; na = 0 or 1; ma = 0-8; ga = 0 or 1; ra = 0-4; R10 = 3-8C cycloalkyl or Ph (optionally substituted by 1-3 F, Cl, CF3, Me or OMe); R4, R5 = H, F, Cl, Br, I, CN, 1-8C alkyl, 1-8C perfluoroalkyl, 3-8C cycloalkyl or Ph (optionally substituted by 1-3 F, Cl, CF3, Me, OMe or NR14R15); R14, R15 = H, 1-4C alkyl or 1-4C perfluoroalkyl.
-
公开(公告)号:CA2229947A1
公开(公告)日:1998-08-20
申请号:CA2229947
申请日:1998-02-19
Applicant: HOECHST AG
Inventor: LANG HANS JOCHEN , WEIDMANN KLAUS , BRENDEL JOACHIM , GERLACH UWE
IPC: C07D311/60 , A61K31/35 , A61K31/352 , A61P1/00 , A61P9/00 , C07D311/68 , C07D311/70 , A61K31/38 , A61K31/415 , A61K31/435 , A61K31/495 , A61K31/535 , C07D311/96 , C07D405/00 , C07D409/00
Abstract: Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them Chromans of the formula I (see fig.I) with the meanings of R(A), R(B) and R(1) to R(8) stated in claim 1 are outstandingly suitable for producing a medicament for blocking the K+ channel which is opened by cyclic adenosine monophosphate (cAMP); also for producing medicaments for inhibiting gastric acid secretion; for the treatment of ulcers of the stomach and the intestinal region, in particular the duodenum, for the treatment of reflux esophagitis, for the treatment of diarrheal disorders, for the treatment and prevention of all types of arrhythmias, including atrial, ventricular and supraventricular arrhythmias, for controlling reentry arrhythmias and for preventing sudden heart death as a result of ventricular fibrillation.
-
公开(公告)号:BR9703342A
公开(公告)日:1998-08-18
申请号:BR9703342
申请日:1997-05-30
Applicant: HOECHST AG
Inventor: GHATE ANIL VASANTRAO , LAL BANSI , LANG HANS JOCHEN , ALBUS UDO , ENGLERT HEINRICH CHRISTIAN , BRENDEL JOACHIM , KLEEMANN HEINZ WERNER
IPC: C07D295/14 , A01N1/02 , A01N47/44 , A61K31/155 , A61K31/165 , A61K31/445 , A61P3/06 , A61P9/00 , A61P9/06 , A61P9/10 , C07C271/22 , C07C279/20 , C07C279/22 , C07C303/40 , C07C311/19 , C07C315/04 , C07C317/50 , C07C319/20 , C07C323/62 , C07C277/08
Abstract: 1-Naphthoyl-guanidines (I) and their salts are new: R2-R8 = H; F; Cl; Br; I; CN; NO2; CF3; C2F5; or XaYbZ; X = O; S; or NR10, CR11R12, CO, CONR10, COO, SO; SO2, SO2NR10, OCO, NR10CO or NR10SO2 attached to the ring via the left hand atom; R10-R12 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-7C cycloalkyl; Y = 1-8C alkylene with 1 CH2 optionally replaced by O, S, NR13 or o-, m- or p-phenylene; R13 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-6C cycloalkyl; Z = H; 1-7C alkyl; 3-7C cycloalkyl; COR15; SO2R15; NR16R17; or is Ph or a C- or N-linked N-containing 1-9C heterocycle (each optionally mono-, di- or trisubstituted by F, Cl, Br, CF3, Me, OMe or NR21R22); a, b = 0 or 1; R15 = N=C(NH2)2; NR18R19; N(CH2)cNR18R19; or OR20; c = 2 or 3; R16 - R19 = H; 1-8C alkyl; or 1-4C perfluoroalkyl; or R16+R17 or R18+R19 = tetra- or pentamethylene with 1 CH2 optionally replaced by O, S or NQ; Q = H; Me; benzyl; or p-Cl-Ph; R20 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-7C cycloalkyl; R21, R22 = H; 1-4C alkyl; or 1-4C perfluoroalkyl; provided that when R4 = alkoxy, at least one of R2, R3 and R5-R8 is not H.
-
公开(公告)号:BR9703338A
公开(公告)日:1998-08-18
申请号:BR9703338
申请日:1997-05-30
Applicant: HOECHST AG
Inventor: LAL BANSI , ENGLERT HEINRICK CHRISTIAN , LANG HANS JOCHEN , BRENDEL JOACHIM , SCHWARK JAN-ROBERT , KLEEMANN HEINZ WERNER , WEICHERT ANDREAS
IPC: C07D295/14 , A01N1/02 , A01N47/44 , A61K31/155 , A61K31/165 , A61K31/27 , A61K31/44 , A61K31/495 , A61K31/535 , A61K31/5375 , A61P3/06 , A61P9/00 , A61P9/06 , A61P9/10 , A61P35/00 , A61P43/00 , C07C271/22 , C07C277/08 , C07C279/20 , C07C279/22 , C07C311/19 , C07C317/50 , C07C323/62 , C07D213/40 , C07D213/75 , C07D295/08 , C07D295/088
Abstract: 2-Naphthoyl-guanidines (I) and their salts are new: R1 and R3-R8 = H; F; Cl; Br; I; CN; NO2; CF3; C2F5; VpQqU; XYaWZ; or X'YaWZ' (at least 1 is XYaWZ or X'YaWZ'); V = O; S; SO; SO2; NR60; OCO; CO; CONR60; COO; or CR66R67; Q = 1-8C alkylene with 1 CH2 optionally replaced by O, S, NR13 or o-, m- or p-phenylene; U = H; 1-7C alkyl; 3-7C cycloalkyl; COR65; SO2R65; NR61R62; or Ph or a N- or C-linked N-containing 1-9C heterocycle optionally mono-, di- or trisubstituted by F, Cl, Br, CF3, Me, OMe or NR63R64; p, q = 0 or 1; X = O; S; NR10; or CR11R12; Y = 1-8C alkylene with 1 CH2 optionally replaced by O, S, NR13 or o-, m- or p-phenylene; W = CH2; SO2; S(O)(NH); or (when W is not attached directly to a hetero atom of XYa) O or NR14; Z = COR15; SO2R15; or (when W is not O or NR14) NR16R17; a = 0 or 1; X' = CO, CONR30, COO, SO, SO2, SO2NR30, OCO, NR30CO or NR30SO2 linked with the ring via the left hand atom; Z' = COR15; SO2R15; a N- or C-linked N-containing 1-9C heterocycle optionally mono-, di- or trisubstituted by F, Cl, Br, CF3, Me, OMe or NR21R22; or (when W is not O or NR14) Z' is NR16R17; R10-R12 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-7C cycloalkyl; R13, R14, R68 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-6C cycloalkyl; R15 = N=C(NH2)2; NR18R19; N(CH2)bNR18R19; or OR20; b = 2 or 3; R16 - R19 = H; 1-8C alkyl; or 1-4C perfluoroalkyl; or R16+R17 or R18+R19 = tetra- or pentamethylene with 1 CH2 optionally replaced by O, S or NA; A = H; Me; benzyl; or p-Cl-Ph; R20, R30; R60; R66; R67 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-7C cycloalkyl; R21, R22; R63, R64 = H; 1-4C alkyl; or 1-4C perfluoroalkyl; R65 = N=C(NH2)2; NR61R62; or OR60; R61, R62 = H; 1-8C alkyl; or 1-4C perfluoroalkyl; or R61+R62 = tetra- or pentamethylene with 1 CH2 optionally replaced by O, S or NA; provided that at least one of R5-R8 is not H.
-
公开(公告)号:AT168683T
公开(公告)日:1998-08-15
申请号:AT94908997
申请日:1994-02-18
Applicant: HOECHST AG
Inventor: PIPER HANS MICHAEL , SCHLUETER KLAUS-DIETER , WEBER MARTIN , SCHOENAFINGER KARL , BRENDEL JOACHIM , SCHRAVEN ECKHARD
IPC: A61K31/275 , A61K31/40 , A61K31/495 , A61K31/54 , C07C255/66 , C07D295/22 , C07D295/30
-
公开(公告)号:NO980564L
公开(公告)日:1998-08-12
申请号:NO980564
申请日:1998-02-10
Applicant: HOECHST AG
Inventor: GERLACH UWE , BRENDEL JOACHIM , LANG HANS JOCHEN , WEIDMANN KLAUS
IPC: C07D335/02 , A61K31/015 , A61K31/18 , A61K31/215 , A61K31/38 , A61K31/382 , A61K31/435 , A61K31/47 , A61P9/00 , C07C13/20 , C07C311/07 , C07C403/04 , C07D211/72 , C07D215/42 , C07D335/06 , C07C311/13
-
公开(公告)号:ZA9801063B
公开(公告)日:1998-08-11
申请号:ZA9801063
申请日:1998-02-10
Applicant: HOECHST AG
Inventor: GERLACH UWE , BRENDEL JOACHIM , LANG HANS JOCHEN , WEIDMANN KLAUS
IPC: C07D335/02 , A61K31/015 , A61K31/18 , A61K31/215 , A61K31/38 , A61K31/382 , A61K31/435 , A61K31/47 , A61P9/00 , C07C13/20 , C07C311/07 , C07C403/04 , C07D211/72 , C07D215/42 , C07D335/06 , C07D , A61K
CPC classification number: C07D335/06 , C07C311/07 , C07C2602/10 , C07D215/42
-
公开(公告)号:NO982989D0
公开(公告)日:1998-06-26
申请号:NO982989
申请日:1998-06-26
Applicant: HOECHST AG
Inventor: WIRTH KLAUS , SCHOLZ WOLFGANG , JANSEN HANS-WILLI , LANG HANS JOCHEN , BRENDEL JOACHIM , KLEEMANN HEINZ-WERNER , SCHWARK JAN-ROBERT , WEICHERT ANDREAS
IPC: A61K31/00 , A61K31/155 , A61K31/165 , A61K31/166 , A61K31/425 , A61K
Abstract: The active ingredients identified as NHE inhibitors are particularly suitable for the preparation of a drug for respiratory stimulation. They are particularly good for treating sleep apnea or other respiratory disorders.
-
-
-
-
-
-
-
-
-